Custom Premix Selecting "Custom Premix" option means that all of the beads you have chosen will be premixed in manufacturing before the kit is sent to you.
Fibrinogen, CAS 9001-32-5 , is a soluble plasma glycoprotein that is synthesized in the hepatic parenchymal cells. Contains mpre than 95% clottable protein.
More>>Fibrinogen, CAS 9001-32-5 , is a soluble plasma glycoprotein that is synthesized in the hepatic parenchymal cells. Contains mpre than 95% clottable protein. Less<<
Fibrinogen, Bovine Plasma MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
Fibrinogen, CAS 9001-32-5 , is a soluble plasma glycoprotein that is synthesized in the hepatic parenchymal cells. Contains mpre than 95% clottable protein.
Biological Information
Purity
homogeneous by SDS-PAGE.
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
R Phrase
R: 20/21/22
Harmful by inhalation, in contact with skin and if swallowed.
S Phrase
S: 36
Wear suitable protective clothing.
Product Usage Statements
Storage and Shipping Information
Ship Code
Ambient Temperature Only
Toxicity
Harmful
Storage
+2°C to +8°C
Do not freeze
Ok to freeze
Special Instructions
Following reconstitution, aliquot and freeze (-20°C) for long term storage or store at room temperature (20°C) for short term storage. Do not store solutions on ice; precipitation will occur. Stock solutions are stable for up to 4 h at 20°C or for up to 6 months at -20°C.
Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.
Revision
22-November-2010 JSW
Synonyms
Coagulation Factor I
Description
Native fibrinogen from bovine plasma. A plasma glycoprotein synthesized and secreted by hepatic parenchymal cells. Fibrinogen, also known as Coagulation Factor I, is an acute-phase plasma protein found at a concentration of about 300 mg/100 ml. Conversion of soluble fibrinogen to the insoluble clot-forming fibrin is the terminal stage of blood clotting. Clinically, fibrinogen is elevated in pregnancy, after surgical trauma, and myocardial infarction, and is decreased in cases of liver cirrhosis and serum hepatitis.
Form
Lyophilized
Formulation
Lyophilized from 20 mM sodium citrate-HCl, pH 7.4.
CAS number
9001-32-5
Purity
homogeneous by SDS-PAGE.
Solubility
Sterile distilled H₂O. Solutions used to reconstitute fibrinogen should first be brought to 37°C. Once at 37°C, the solution can be added to the fibrinogen and this mixture should remain at 37°C until the fibrinogen is completely solubilized.
Storage
+2°C to +8°C
Do Not Freeze
Ok to freeze
Special Instructions
Following reconstitution, aliquot and freeze (-20°C) for long term storage or store at room temperature (20°C) for short term storage. Do not store solutions on ice; precipitation will occur. Stock solutions are stable for up to 4 h at 20°C or for up to 6 months at -20°C.
